128 related articles for article (PubMed ID: 11009605)
1. Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein.
Urbatsch IL; Gimi K; Wilke-Mounts S; Senior AE
Biochemistry; 2000 Oct; 39(39):11921-7. PubMed ID: 11009605
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of conserved carboxylate residues in the nucleotide binding sites of P-glycoprotein.
Urbatsch IL; Julien M; Carrier I; Rousseau ME; Cayrol R; Gros P
Biochemistry; 2000 Nov; 39(46):14138-49. PubMed ID: 11087362
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein catalytic mechanism: studies of the ADP-vanadate inhibited state.
Urbatsch IL; Tyndall GA; Tombline G; Senior AE
J Biol Chem; 2003 Jun; 278(25):23171-9. PubMed ID: 12670938
[TBL] [Abstract][Full Text] [Related]
4. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
[TBL] [Abstract][Full Text] [Related]
5. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
Urbatsch IL; Beaudet L; Carrier I; Gros P
Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
[TBL] [Abstract][Full Text] [Related]
6. Large scale purification of detergent-soluble P-glycoprotein from Pichia pastoris cells and characterization of nucleotide binding properties of wild-type, Walker A, and Walker B mutant proteins.
Lerner-Marmarosh N; Gimi K; Urbatsch IL; Gros P; Senior AE
J Biol Chem; 1999 Dec; 274(49):34711-8. PubMed ID: 10574938
[TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation bypasses the requirement for ATP hydrolysis in regenerating low affinity transition state conformation of human P-glycoprotein.
Maki N; Moitra K; Ghosh P; Dey S
J Biol Chem; 2006 Apr; 281(16):10769-77. PubMed ID: 16505485
[TBL] [Abstract][Full Text] [Related]
8. Analysis of catalytic carboxylate mutants E552Q and E1197Q suggests asymmetric ATP hydrolysis by the two nucleotide-binding domains of P-glycoprotein.
Carrier I; Julien M; Gros P
Biochemistry; 2003 Nov; 42(44):12875-85. PubMed ID: 14596601
[TBL] [Abstract][Full Text] [Related]
9. Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis.
Sauna ZE; Smith MM; Muller M; Ambudkar SV
J Biol Chem; 2001 Jun; 276(24):21199-208. PubMed ID: 11287418
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and characterization of cysteine-free mouse P-glycoprotein.
Tombline G; Urbatsch IL; Virk N; Muharemagic A; White LB; Senior AE
Arch Biochem Biophys; 2006 Jan; 445(1):124-8. PubMed ID: 16343415
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of N-terminal nucleotide binding domain (NBD-1) of a major ABC drug transporter Cdr1p of Candida albicans: uncommon but conserved Trp326 of Walker B is important for ATP binding.
Rai V; Shukla S; Jha S; Komath SS; Prasad R
Biochemistry; 2005 May; 44(17):6650-61. PubMed ID: 15850398
[TBL] [Abstract][Full Text] [Related]
12. Conformational changes of the bacterial type I ATP-binding cassette importer HisQMP2 at distinct steps of the catalytic cycle.
Heuveling J; Frochaux V; Ziomkowska J; Wawrzinek R; Wessig P; Herrmann A; Schneider E
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):106-16. PubMed ID: 24021237
[TBL] [Abstract][Full Text] [Related]
13. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.
van Veen HW; Margolles A; Müller M; Higgins CF; Konings WN
EMBO J; 2000 Jun; 19(11):2503-14. PubMed ID: 10835349
[TBL] [Abstract][Full Text] [Related]
14. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein.
Chufan EE; Kapoor K; Ambudkar SV
Biochem Pharmacol; 2016 Feb; 101():40-53. PubMed ID: 26686578
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of P-glycoprotein ATPase activity by procedures involving trapping of nucleotide in catalytic sites.
Sankaran B; Bhagat S; Senior AE
Arch Biochem Biophys; 1997 May; 341(1):160-9. PubMed ID: 9143365
[TBL] [Abstract][Full Text] [Related]
16. The characteristics of the (alpha V371C)3(beta R337C)3 gamma double mutant subcomplex of the TF1-ATPase indicate that the catalytic site at the alpha TP-beta TP interface with bound MgADP in crystal structures of MF1 represents a catalytic site containing inhibitory MgADP.
Bandyopadhyay S; Muneyuki E; Allison WS
Biochemistry; 2005 Feb; 44(7):2441-8. PubMed ID: 15709756
[TBL] [Abstract][Full Text] [Related]
17. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
Qu Q; Russell PL; Sharom FJ
Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
[TBL] [Abstract][Full Text] [Related]
18. Synergy between conserved ABC signature Ser residues in P-glycoprotein catalysis.
Tombline G; Bartholomew L; Gimi K; Tyndall GA; Senior AE
J Biol Chem; 2004 Feb; 279(7):5363-73. PubMed ID: 14638679
[TBL] [Abstract][Full Text] [Related]
19. Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein.
Ledwitch KV; Gibbs ME; Barnes RW; Roberts AG
Biochem Pharmacol; 2016 Oct; 118():96-108. PubMed ID: 27531061
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes.
Sauna ZE; Ambudkar SV
J Biol Chem; 2001 Apr; 276(15):11653-61. PubMed ID: 11154703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
